Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China · Delayed Price · Currency is CNY 30.89
-0.62 (-1.97%)
Sep 18, 2025, 2:45 PM CST
SHA:603882 Revenue
Guangzhou Kingmed Diagnostics Group had revenue of 1.53B CNY in the quarter ending June 30, 2025, a decrease of -24.97%. This brings the company's revenue in the last twelve months to 6.31B, down -22.27% year-over-year. In the year 2024, Guangzhou Kingmed Diagnostics Group had annual revenue of 7.19B, down -15.81%.
Revenue (ttm)
6.31B
Revenue Growth
-22.27%
P/S Ratio
2.29
Revenue / Employee
605.55K
Employees
10,413
Market Cap
14.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.19B | -1.35B | -15.81% |
| Dec 31, 2023 | 8.54B | -6.94B | -44.82% |
| Dec 31, 2022 | 15.48B | 3.53B | 29.58% |
| Dec 31, 2021 | 11.94B | 3.70B | 44.88% |
| Dec 31, 2020 | 8.24B | 2.97B | 56.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |